1 – 26 of 26
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Metabolic parameters of [18F]FDG PET-CT before and after radiotherapy may predict survival and recurrence in cervical cancer
(
- Contribution to journal › Article
-
Mark
Decreasing the Adverse Effects in Pelvic Radiation Therapy : A Randomized Controlled Trial Evaluating the Use of Probiotics
(
- Contribution to journal › Article
-
Mark
Imaging ovarian cancer - from baseline characteristics to high-risk image factors
(
- Contribution to journal › Article
- 2022
-
Mark
Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation : OPINION primary analysis
(
- Contribution to journal › Article
-
Mark
The wait time to primary surgery in endometrial cancer–impact on survival and predictive factors : a population-based SweGCG study
(
- Contribution to journal › Article
-
Mark
Long-term incidence of endometrial cancer after endometrial resection and ablation : A population based Swedish gynecologic cancer group (SweGCG) study
(
- Contribution to journal › Article
- 2021
-
Mark
Survival in endometrial cancer in relation to minimally invasive surgery or open surgery – a Swedish Gynecologic Cancer Group (SweGCG) study
(
- Contribution to journal › Article
-
Mark
Implementation of National Guidelines increased survival in advanced ovarian cancer - A population-based nationwide SweGCG study
(
- Contribution to journal › Article
- 2020
-
Mark
Primary treatment and relative survival by stage and age in vulvar squamous cell carcinoma : A population-based SweGCG study
(
- Contribution to journal › Article
-
Mark
Ovarian cancer subtypes and survival in relation to three comprehensive imaging parameters
(
- Contribution to journal › Article
- 2019
-
Mark
Primary treatment patterns and survival of cervical cancer in Sweden : A population-based Swedish Gynecologic Cancer Group Study
(
- Contribution to journal › Article
-
Mark
Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer - a Swedish Gynecologic Cancer Group (SweGCG) study
(
- Contribution to journal › Article
- 2018
-
Mark
Lymph node metastases as only qualifier for stage IV serous ovarian cancer confers longer survival than other sites of distant disease – a Swedish Gynecologic Cancer Group (SweGCG) study
(
- Contribution to journal › Article
-
Mark
Data quality in the Swedish Quality Register of Gynecologic Cancer – a Swedish Gynecologic Cancer Group (SweGCG) study
(
- Contribution to journal › Article
- 2017
-
Mark
Risk factors for lymph node metastases in women with endometrial cancer : A population-based, nation-wide register study—On behalf of the Swedish Gynecological Cancer Group
(
- Contribution to journal › Article
-
Mark
Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG)
(
- Contribution to journal › Article
- 2016
-
Mark
Double-blind, placebo-controlled, randomized phase III trial evaluating pertuzumab combined with chemotherapy for low tumor human epidermal growth factor receptor 3 mRNA-Expressing platinum-resistant ovarian Cancer (PENELOPE)
(
- Contribution to journal › Article
- 2015
-
Mark
Cell proliferation, measured as flow cytometric S-phase fraction, is a strong prognostic indicator in FIGO stage I endometrioid endometrial carcinoma: a population-based study.
(
- Contribution to journal › Article
-
Mark
Cervixcancer en klinisk utmaning
(
- Contribution to journal › Article
- 2013
-
Mark
Clinical Impact of 2-Deoxy-2-[18F]fluoro-D-Glucose (FDG)-Positron Emission Tomography (PET) on Treatment Choice in Recurrent Cancer of the Cervix Uteri.
(
- Contribution to journal › Article
- 2010
-
Mark
FDG-PET in Cervical Cancer - Translational Studies
(
- Thesis › Doctoral thesis (compilation)
- 2009
-
Mark
Early changes in 2-deoxy-2-[18F]fluoro-D-glucose metabolism in squamous-cell carcinoma during chemotherapy in vivo and in vitro.
(
- Contribution to journal › Article
-
Mark
Prediction of patient outcome with 2-deoxy-2-[18F]fluoro-D-glucose-positron emission tomography early during radiotherapy for locally advanced cervical cancer.
(
- Contribution to journal › Article
- 2008
-
Mark
Hypoxia-mediated induction of the polyamine system provides opportunities for tumor growth inhibition by combined targeting of vascular endothelial growth factor and ornithine decarboxylase.
(
- Contribution to journal › Article
- 2006
-
Mark
FDG-PET in the detection of residual disease and relapse in patients with Hodgkin's lymphoma. Experience from a Swedish centre.
(
- Contribution to journal › Article
- 2003
-
Mark
Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: A pilot study of a new digitized scalp-cooling system used in 74 patients.
(
- Contribution to journal › Article